PV

Peda Venkata Subbarao Seja

Active Director Director DIN 09653805
DIN 09653805 First appointment Jun 2022 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Peda Venkata Subbarao Seja

Data last updated:

Peda Venkata Subbarao Seja is a Director at Bryoptera Pharmaceuticals Private Limited (since 2022). The company operates in Research & Development.

DIN 09653805
Primary Designation Director
Industry Research & Development
First Appointment 27 Jun 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20222022Active

Board colleagues of Peda Venkata Subbarao Seja

Directorship timeline

Open interactive timeline →
Bryoptera Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Peda Venkata Subbarao Seja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peda Venkata Subbarao Seja

Peda Venkata Subbarao Seja currently holds 1 directorship: Bryoptera Pharmaceuticals Private Limited (Director, since 27 Jun 2022).

Peda Venkata Subbarao Seja was first appointed on 27 Jun 2022 as Director at Bryoptera Pharmaceuticals Private Limited.

The current boards of Peda Venkata Subbarao Seja's companies include Jonnagurakala Jyothi Reddy (Bryoptera Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available